# Use of Ibandronate in Diabetic Patients

> **NCT05266261** · NA · COMPLETED · sponsor: **Yeouido St. Mary's Hospital** · enrollment: 121 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal
- Type 2 Diabetes

## Interventions

- **DRUG:** Ibandronate Oral Tablet

## Key facts

- **NCT ID:** NCT05266261
- **Lead sponsor:** Yeouido St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-08-30
- **Final completion:** 2022-01-31
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2022-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266261, "Use of Ibandronate in Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05266261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*